IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert DeHaven who wrote (285)	3/17/1998 4:38:00 PM
From: jake burns	of 1510

I think the stock fell on news from Immunex' president that he was optimistic that Enbrel, their rheumatoid arthritis drug, would get fda fast track approval by year end. IMNX was up over 3 bucks today off the news. What do the immunologists out there know about Enbrel vis-a-vis IMNR's product? Which has had better trials? Do they directly compete with each other? It would be nice to get some good news. The company has stated that they hope to have corporate partnership(s) announced this quarter. We've got 2 more weeks. I suspect that would bump the stock up a bit. The announcement today re: the patent litigation certainly was good news. But we still can't break through the 11 dollar barrier. I'm very bullish, though.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next